3. NHS England
Policy Consequences
•
•
•
•
Give power to the people who know the patients best
Move the locus of care from hospital towards home
Large Tenders: NHS Cornwall £300m, Cambridge £800m
Technology Fund £500m Nurse Tech: £250m A&E £1bn
Future Policy
• Vertically integrated Primary Care with Secondary Care
• Horizontally integrated health care and social care
(£3.8bn Integration Fund)
• Long term condition management will become social care
functions
4. Global Response
to Chronic Disease
2011 was a watershed year in human society’s acceptance of non-communicable disease
The General Assembly of the United Nations in its resolution A/RES/65/238
decided that the high-level meeting of the General Assembly on the
prevention and control of non-communicable diseases shall be held on 19 and
20 September 2011 in New York
Whole System Demonstrator: Headline Results: 20% reduction in emergency
admissions, 15% reduction in A&E visits, 14% reduction in elective admissions 14%
reduction in bed days, 8% reduction in tariff costs, 45% reduction in mortality rates
The aim – to improve three million lives over the next five
years. This is going to make an extraordinary difference to
people.”
Rt Hon David Cameron MP, Prime Minister, 5 December 2011
FT Global Pharmaceutical and Biotechnology Conference 2011
6. 3millionlives
and Continua
Continua On-Ramp:
To achieve end-to-end
interoperability, Personal Health
Device providers must meet the
specifications under CEN ISO/IEEE
11073 Health Informatics for medical
/ health device communication
standards.
Continua Off-Ramp:
Services will implement, current and
future, applicable Interoperability ToolKit specifications, e.g. the Personal
Health Monitoring Report based on
Continua Health Record Network
interface.
8. Dr. M.J. Rice
Principal Consultant
Kokomo
www.kokomo.eu
London (44) : 074 387 89155
Dublin (353) : 086 823 1447
@malachyrice
Editor's Notes
ObjectiveValidate current PHMR definition with wider clinical audience Review E2E process and ID Telehealth specificOverlaps with other standard processes e.g. referalls, CAF – build not reinventDevelop and validate clinical information requirements to point of confidence for next investment step – message development and subsequent spine releaseSignificant achievements/activities - What has been completed?Validation with User Champions – WSDAN and other leadersBuilding expanding network of real clinical users – required for clinical credibility, safety and valueProgramme of review events with volunteering usersWhat does it mean for audience?Opportunity to ensure national proposals incorporate local thinkingConsolidated and validated set of requirements (clarity of reasons for acceptance)Still need contributions from wider sourcesVOLUNTEERS